Patient group direction for Spikevax® Original/Omicron COVID-19 vaccine

Document first published:
Page updated:
Topic:
,
Publication type:

This patient group direction (PGD) is for the administration of Spikevax® bivalent Original/Omicron COVID-19 vaccine to individuals 18 years and over as a booster dose in accordance with the national COVID-19 vaccination programme.

Summary

Providers must check that they are using the current version of the PGD. Amendments may become necessary prior to the published expiry date. Published 24 August 2022.

Summary

Providers must check that they are using the current version of the PGD. Amendments may become necessary prior to the published expiry date. Published 24 August 2022.